Careers  |  Sign In  |  Register

Latest in Surgery

Reuters Health • The Doctor's Channel Daily Newscast

Adjuvant imatinib for three years advisable after GI stromal tumor resection

NEW YORK (Reuters Health) – In a European study, patients at high risk of recurrent gastrointestinal stromal tumor (GIST) who received imatinib (Gleevec; Novartis) for three years after surgery lived longer free of recurrence than their peers who took the drug for only one year following surgery. The...

Reuters Health • The Doctor's Channel Daily Newscast

Substernal goiter may be an under-recognized cause of OSA

NEW YORK (Reuters Health) – Goiter should be considered in the differential diagnosis of positional dyspnea, even in patients without obvious thyroid enlargement, according to a new retrospective analysis published online March 19 in the Archives of Surgery. “People are more symptomatic from thyroid...

Reuters Health • The Doctor's Channel Daily Newscast

Varicocele surgery improves sperm parameters regardless of technique

NEW YORK (Reuters Health) – Varicocelectomy leads to significant improvements in sperm count and motility, regardless of surgical technique (i.e., high ligation, inguinal or subinguinal approach), a meta-analytic review of relevant research indicates. The data also hint that the inguinal approach may be...